BioTek Germany Certified in Accordance with EN ISO 13485
News Dec 17, 2012
BioTek Germany was recently awarded certification in accordance with EN ISO 13485:2003.
This certification confirms that administration, sales and distribution, warehouse management, service/repair, and installation at the subsidiary all fulfill the quality management system requirements for medical devices as set out in this standard.
BioTek's manufacturing facility and headquarters in Winooski, Vermont is similarly certified in accordance with EN ISO 13485.
BioTek's EN ISO 13485 certification guarantees that all of its products and services satisfy the requirements, and comply with the currently valid legislation, relating to medical devices.
Thomas Brunner, Managing Director of BioTek Instruments, GmbH, explains, "Medical technology products must fulfill the most rigorous safety criteria. The fact that our quality management system complies with EN ISO 13485 - which goes above and beyond the requirements of ISO 9001 - proves that we are committed to ensuring quality and efficiency. It also provides our customers with documentary evidence that our development processes and methods meet the highest standards in the field of medical technology."
New Ovarian Cancer TargetNews
Researchers have found a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium deficiency and kidney diseases, may increase the likelihood of surviving ovarian cancer. This new study opens a potential avenue for treating ovarian cancer. Since Calcitriol is an FDA-approved drug, no additional research is needed before the drug can advance to human clinical trials for ovarian cancer.READ MORE
Novel Microplate 3D Bioprinting Platform for Engineering Muscle and Tendon TissuesNews
There is a strong need for medication that treats age-related degenerative muscle and tendon diseases. A critical bottleneck in the discovery and development of novel drugs for skeletal muscle is the lack of efficient and robust functional in vitro assays for compound screening. Researchers describe the development of a novel screening platform with automated production of 3D muscle- and tendon–like tissues using 3D bioprinting.READ MORE
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE